Surveillance

Unmanned Ground Vehicles Market Report 2022: Rapid Adoption of Autonomous Systems in Defense and Commercial Sectors Fuels Growth

Retrieved on: 
Friday, April 7, 2023
Intelligence, SLAM, Theft, Human, Travel, UGV Interoperability Profile, DARPA, Satellite navigation, CBRN, T4, Rheinmetall, GNSS, RPV, Law enforcement, Star Patrol Mission Master Pack, ARV, ISR, L3Harris Technologies, Build automation, EOD, UGV, Research, USD, XM1219 Armed Robotic Vehicle, S series, Internet, Disaster, Improvised explosive device, Application, Risk, Police, Machine learning, Dog, Map, Tyndall Air Force Base, Simultaneous localization and mapping, Artificial intelligence, Observation, Growth, Weather, Hacking, Mobility, Transport, Commercial, Environment, Complex, Safety, Software, Shipbuilding, Surveying, Satellite navigation device, Reconnaissance, Surveillance, AFB

The market growth is being driven by the increasing adoption of autonomous systems in both commercial and defense sectors, as well as the development of UGV payloads for combat operations and the growing demand for autonomous control systems.

Key Points: 
  • The market growth is being driven by the increasing adoption of autonomous systems in both commercial and defense sectors, as well as the development of UGV payloads for combat operations and the growing demand for autonomous control systems.
  • Autonomous Unmanned Ground Vehicles (UGVs) are typically utilized in challenging terrain, harsh environments, or areas that are inaccessible to humans, significantly reducing the risk of injury to defense personnel.
  • To improve the safety of forces on the battlefield, research and development efforts are underway to design and construct autonomous unmanned defense systems and vehicles.
  • The global unmanned ground vehicle market is segmented based on navigation systems into payloads, navigation systems, controller systems, power systems, and others.

AAR signs distribution agreement with Cloud Cap Technology, a Collins Aerospace Mission Systems business

Retrieved on: 
Monday, March 27, 2023
Cloud, Intelligence, Collins, UAS, Original equipment manufacturer, Unmanned aerial vehicle, Aviation, ISR, Indian MRO Industry, Government, AIR, TASE, AAR, RIM-116 Rolling Airframe Missile, NYSE, Piccolo, Reconnaissance, Surveillance

Wood Dale, Illinois, March 27, 2023 (GLOBE NEWSWIRE) -- AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, announced a distribution agreement with Cloud Cap Technology, a Collins Aerospace Mission Systems business.

Key Points: 
  • Wood Dale, Illinois, March 27, 2023 (GLOBE NEWSWIRE) -- AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, announced a distribution agreement with Cloud Cap Technology, a Collins Aerospace Mission Systems business.
  • This agreement expands AAR’s presence in the Unmanned Aerial System (UAS) market, building on AAR’s civil and government relationships as well as its proven supply chain and sales support processes.
  • “We look forward to working with AAR to grow our global reach for TASE and Piccolo,” said Guy Bowie, General Manager for TASE and Piccolo at Collins.
  • “The AAR team brings an increased capability that will serve our customers well.”
    “Cloud Cap is the field-tested market leader with the TASE and Piccolo systems,” said Darren Spiegel, Vice President and General Manager at AAR.

QSAM Biosciences Receives Clearance from FDA to Expand Enrollment Criteria in its Phase 1 Study of CycloSam® Targeting Metastatic Bone Cancer

Retrieved on: 
Wednesday, March 8, 2023
QSAM, Surveillance, Bone metastasis, Label, Protocol, Oncology, OTCQB, FDA, Safety, Prostate cancer, Metastasis, Collection, Clinical trial, Breast cancer, Internal medicine, Cancer, Patient, Prevalence, Bone, NIH, Pharmaceutical industry, Medical imaging, Epidemiology

This amendment to the enrollment criteria significantly expands the population of potential participants in QSAM’s Phase 1 study evaluating CycloSam® in the treatment of bone cancer.

Key Points: 
  • This amendment to the enrollment criteria significantly expands the population of potential participants in QSAM’s Phase 1 study evaluating CycloSam® in the treatment of bone cancer.
  • The prevalence of bone metastases in patients over age 70 is greater than 30% among breast cancer patients and almost 50% for prostate cancer patients, according to recently published literature from the NIH SEER database (Surveillance, Epidemiology, and End Results).
  • Older patients comprise a significant percentage of the current population of patients with metastatic bone cancer that is targeted by the CycloSam® drug product.
  • Our mission at QSAM is making sure the broadest possible population fighting this deadly disease may one day be able to benefit from CycloSam®.”

American Cancer Society Releases New Colorectal Cancer Statistics; Rapid Shifts to More Advanced Disease and Younger People

Retrieved on: 
Wednesday, March 1, 2023
Tissue, Alaska Natives, Colonoscopy, SEER, American Cancer Society Cancer Action Network, Surveillance, Cancer, Human, Diagnosis, Disease, Policy, ACS, Mortality, National Center for Health Statistics, North American Association of Central Cancer Registries, Colorectal cancer, Lymph, Health equity, National Cancer Institute, Research, Medical statistics, CMS, BBB National Programs, Meat, American Cancer Society, National Center for Complementary and Integrative Health, Medicare, CRC, Cost sharing, Large intestine, Centers for Medicare & Medicaid Services, Woman, Incidence, Dairy, Health insurance, Vaccine, Pharmaceutical industry, Epidemiology

ATLANTA, March 1, 2023 /PRNewswire/ -- Colorectal cancer is swiftly shifting to more advanced disease and younger individuals according to Colorectal Cancer Statistics 2023, a new report on cancer facts and trends by the American Cancer Society (ACS).

Key Points: 
  • ATLANTA, March 1, 2023 /PRNewswire/ -- Colorectal cancer is swiftly shifting to more advanced disease and younger individuals according to Colorectal Cancer Statistics 2023, a new report on cancer facts and trends by the American Cancer Society (ACS).
  • Overall, in 2023, an estimated 153,020 people will be diagnosed with CRC in the U.S., and 52,550 people will die from the disease.
  • These major findings are to be published today in CA: A Cancer Journal for Clinicians , alongside its consumer-friendly companion, Colorectal Cancer Facts & Figures 2023-2025, available on cancer.org .
  • "These highly concerning data illustrate the urgent need to invest in targeted cancer research studies dedicated to understanding and preventing early-onset colorectal cancer," said Dr. Karen E. Knudsen , CEO of the American Cancer Society.

Semiconductor in Military and Aerospace Market to Reach $12.9 Billion, Globally, by 2031 at 7.6% CAGR: Allied Market Research

Retrieved on: 
Monday, February 27, 2023
Human, Semiconductor, RF, Optoelectronics, Artificial intelligence, National Aeronautic Association, Sensor, Aircraft, NASA, GPS, Communication, Investment, Automation, Science and technology in Asia, Growth, Micro, Memory, Radio, Government, Logic, Machine learning, Electronics, Wholesale Applications Community, Navigation, Radar, COVID-19, Component, Arms industry, Video game, Surveillance, Analog, Imaging

PORTLAND, Ore., Feb. 27, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Semiconductor in Military and Aerospace Market by Component (Sensors, Memory, Opto Electronics, Logic, Micro, Analog, and Others), Technology (Surface Mount Technology and Through-Hole Technology), End Use (Military and Aerospace), and Application (Communication, Navigation, Global Positioning System (GPS) and Surveillance, Imaging, Radar and Earth Observation, Munitions, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2031". According to the report, the global semiconductor in the military and aerospace industry is expected to generate $6.3 billion in 2021 and is anticipated to generate $12.9 billion in 2031, witnessing a CAGR of 7.6% from 2022 to 2031.        

Key Points: 
  • The rise in military expenditure as well as growth in aircraft upgradation and modernization programs support the growth of the global semiconductor in the military and aerospace market.
  • The rise in military expenditure as well as growth in aircraft upgradation and modernization programs support the growth of the global semiconductor in the military and aerospace market.
  • The use of radiation-tolerant semiconductor components also boosts the growth of semiconductors in the military and aerospace market.
  • The COVID-19 pandemic has hurt the overall military & aerospace component manufacturing and, in turn, the semiconductor in the military & aerospace industry.

Semiconductor in Military and Aerospace Market to Reach $12.9 Billion, Globally, by 2031 at 7.6% CAGR: Allied Market Research

Retrieved on: 
Monday, February 27, 2023
Human, Semiconductor, RF, Optoelectronics, Artificial intelligence, National Aeronautic Association, Sensor, Aircraft, NASA, GPS, Communication, Investment, Automation, Science and technology in Asia, Growth, Micro, Memory, Radio, Government, Logic, Machine learning, Electronics, Wholesale Applications Community, Navigation, Radar, COVID-19, Component, Arms industry, Video game, Surveillance, Analog, Imaging

PORTLAND, Ore., Feb. 27, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Semiconductor in Military and Aerospace Market by Component (Sensors, Memory, Opto Electronics, Logic, Micro, Analog, and Others), Technology (Surface Mount Technology and Through-Hole Technology), End Use (Military and Aerospace), and Application (Communication, Navigation, Global Positioning System (GPS) and Surveillance, Imaging, Radar and Earth Observation, Munitions, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2031". According to the report, the global semiconductor in the military and aerospace industry is expected to generate $6.3 billion in 2021 and is anticipated to generate $12.9 billion in 2031, witnessing a CAGR of 7.6% from 2022 to 2031.        

Key Points: 
  • The rise in military expenditure as well as growth in aircraft upgradation and modernization programs support the growth of the global semiconductor in the military and aerospace market.
  • The rise in military expenditure as well as growth in aircraft upgradation and modernization programs support the growth of the global semiconductor in the military and aerospace market.
  • The use of radiation-tolerant semiconductor components also boosts the growth of semiconductors in the military and aerospace market.
  • The COVID-19 pandemic has hurt the overall military & aerospace component manufacturing and, in turn, the semiconductor in the military & aerospace industry.

Global Ovarian Cancer Drugs Market Report 2022-2027: Analysis by Alkylating Agents, Mitotic Inhibitors, Antirheumatics, Antipsoriatics, VEGF/VEGFR Inhibitors, PARP Inhibitors, & Antineoplastics

Retrieved on: 
Monday, January 23, 2023
Cancer Research UK, Female, III, Paclitaxel, Incidence, Ovarian cancer, National Cancer Institute, BRCA1, Life, Malignancy, Environment, Fatality, Bevacizumab, Government, Liver, Drug combination, American Cancer Society, FDA, Bloating, Growth, Cancer, Somatic symptom disorder, Breast, BRCA2, Prevalence, Market, Pelvic pain, Surveillance, API, Roche, Cell proliferation, Organization, Woman, Lymph, Risk, Carboplatin, SEER, Research, Pharmaceutical industry, Birth control, Epidemiology

The global ovarian cancer drugs market is anticipated to witness an impressive growth during the forecast period, 2023-2027

Key Points: 
  • The global ovarian cancer drugs market is anticipated to witness an impressive growth during the forecast period, 2023-2027
    Ovarian Cancer is one of the most severe and common cancer that affects the women these days.
  • According to the American Cancer Society estimations, the inherited genetic factors contribute to about 10% of occurrences of ovarian cancer.
  • The market for ovarian cancer drugs is growing in a highly favourable environment due to the recent increase in ovarian cancer cases.
  • Company Profiles: Detailed analysis of the major companies present in global ovarian cancer drugs market.

B Batten Welcomes Combat Veteran and Navy SEAL Eddie Penney as Emergency Preparation Expert

Retrieved on: 
Monday, January 23, 2023
Safety, Penney, Executive protection, Knowledge, Autobiography, Navy, SOCOM U.S. Navy SEALs (video game), Coparenting, Surveillance, SEAL Team Six, SEAL, M1133 Medical Evacuation Vehicle, United States Navy SEALs, Emergency, Online shopping, Cryptocurrency, Batten, DALLAS

DALLAS, Jan. 23, 2023 /PRNewswire-PRWeb/ -- Batten, a digital marketplace platform providing expert vetted and consumer recommended security solutions, is pleased to welcome Eddie Penney as an Emergency Preparation Expert to the Batten team.

Key Points: 
  • Batten, a digital marketplace platform providing expert vetted and consumer recommended security solutions, is pleased to welcome Eddie Penney as an Emergency Preparation Expert to the Batten team.
  • DALLAS, Jan. 23, 2023 /PRNewswire-PRWeb/ -- Batten , a digital marketplace platform providing expert vetted and consumer recommended security solutions, is pleased to welcome Eddie Penney as an Emergency Preparation Expert to the Batten team.
  • As a combat veteran and Navy SEAL of over 20 years, Penney will bring extensive operational experience and an invaluable perspective to the Batten team.
  • "We couldn't be more proud to have Eddie join the team as our Emergency Preparation expert," said Patrick Robinson, founder and CEO of Batten.

Global Ovarian Cancer Drugs Market Analysis Report 2022-2027: Ovarian Cancer Drugs Sector will Soon Experience Significant Growth in Developed Nations - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 19, 2023
Health, Oncology, Ovarian cancer, National Cancer Institute, American Cancer Society, Roche, Bevacizumab, Symptoms of COVID-19, BRCA1, Pelvic pain, Government, Cell proliferation, Breast, Malignancy, FDA, Surveillance, Risk, Environment, Carboplatin, Bloating, Organization, Woman, API, Growth, SEER, Prevalence, BRCA2, Lymph, Research, Cancer, Cancer Research UK, Liver, Fatality, Drug combination, III, Incidence, Market share, Life, Paclitaxel, Female, Pharmaceutical industry, Birth control, Dietary supplement, Epidemiology

According to the American Cancer Society estimations, the inherited genetic factors contribute to about 10% of occurrences of ovarian cancer.

Key Points: 
  • According to the American Cancer Society estimations, the inherited genetic factors contribute to about 10% of occurrences of ovarian cancer.
  • The market for ovarian cancer drugs is growing in a highly favourable environment due to the recent increase in ovarian cancer cases.
  • Therefore, it is anticipated that the ovarian cancer drugs sector will soon experience significant growth in developed nations.
  • Company Profiles: Detailed analysis of the major companies present in global ovarian cancer drugs market.

International Defence Trade Directory & Buyers Guide 2023 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 13, 2023
Other Defense, Defense, Database, Intelligence and Security Service of the Ministry of Defence (Slovenia), Webster's Microcomputer Buyer's Guide, Procurement, Navy, Communication, Arms, Directory, Royal Australian Navy Submarine Service, Warehouse, Security, Weapon, Aviation, Surveillance

The "International Defence Trade Directory & Buyers Guide 2023" directory has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "International Defence Trade Directory & Buyers Guide 2023" directory has been added to ResearchAndMarkets.com's offering.
  • The International Defence Trade Directory & Buyers Guide is the most comprehensive and accurate resource on companies and executives trading in the defence and security industry worldwide.
  • The International Defence Trade Directory & Buyers Guide is an indispensable guide lists all available information on the activities of, and products bought by the world's armed forces and those that supply them.
  • The Directory has extensive contact details and provides a rich database of the world's companies in defence manufacture and supplies.